ACTRIMS Forum Takeaways and Unmet Needs in Multiple Sclerosis: Bruce Bebo, PhD
The executive vice president of the National MS Society spoke on the primary theme of ‘biomarkers’ at this year’s meeting, as well as the areas he believes require the most attention for patients with MS. [WATCH TIME: 3 minutes]
WATCH TIME: 3 minutes
“There's already a lot of excitement around the potential of identifying people at high risk for MS during this prodromal phase, and certainly biomarkers are going to be a key piece to that.”
The theme of this year’s
When asked about the areas of unmet need in MS, Bebo noted that althoughthere has been progress made for treatment of relapsing forms of the disease, there is need to further investigate disease-modifying approaches to progressive forms of MS. Identifying those that are at risk of developing MS is another area, with health care professionals (HCPs) then incorporating wellness activities or disease modification strategies if they are able to identify those who are most likely to develop the disease. While there are ongoing clinical prevention trials in conditions like Parkinson disease and rheumatoid arthritis, Bebo said, research efforts are moving the field closer to applying this strategy in MS as well.
For more coverage of ACTRIMS Forum 2022,
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
Pathophysiology of Myasthenia GravisSeptember 18th 2025
